BPG is committed to discovery and dissemination of knowledge
Basic Study
©The Author(s) 2025.
World J Gastrointest Surg. Oct 27, 2025; 17(10): 111454
Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.111454
Figure 3
Figure 3 SLC39A14 expression and survival analysis in The Cancer Genome Atlas cohorting. A: SLC39A14 expression in cancer patients (T) and normal individuals (N) (P < 0.05); B: Changes in SLC39A14 expression across cancer stages; C: Overall survival in male patients with high and low SLC39A14 expression (P = 0.017); D: Overall survival in female patients with high and low SLC39A14 expression (P = 0.2).


Write to the Help Desk